Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
50%
Ph phase_4
1
25%

Phase Distribution

2

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 4Post-market surveillance
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (66.7%)
Phase 41 (33.3%)

Trials by Status

completed250%
unknown125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Precision Medicine in the Treatment of Epilepsy

NCT05450822
unknownphase_4

The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy

NCT05748236
completedphase_1

Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions

NCT04938856
completedphase_1

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

NCT00605371

Clinical Trials (4)

Showing 4 of 4 trials
NCT05450822

Precision Medicine in the Treatment of Epilepsy

Recruiting
NCT05748236Phase 4

The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy

Unknown
NCT04938856Phase 1

Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions

Completed
NCT00605371Phase 1

Bioequivalence and Food Effect of 250mg of Lamotrigine XR

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4